The overall goal of this Project is to examine small molecules synthesized in Project #1 for their ability to disrupt dual specificity phosphatase (DSPase) activity and for their anti-proliferative activity against human solid tumors. This is one of two biochemical components of the Program Project. Our working hypothesis is that the phosphatase activity of some DSPases is responsible for oncogenesis and that selective inhibitors of this activity would generate useful and novel therapeutic agents.
Our Specific Aims are (1) to characterize the in vitro anti-phosphatase activity of all of the novel library compounds, (2) to determine the anti- proliferative effects of the novel library compounds, (3) to assess the anti-phosphatase, anti-proliferative and cell cycle effects of highly active lead compounds and, (4) We will use human breast, prostate and ovarian tumor cells. Moreover, cells with selected temperature sensitive cell cycle control mutations and isogenic cell models, including transformed mouse fibroblasts that over-express Cdc25 DSPases and fibroblasts from mice that lack functional Cdc25A or CDC25B genes, will be incorporated into our assays protocols.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA078039-04
Application #
6419384
Study Section
Project Start
2001-03-01
Project End
2002-02-28
Budget Start
Budget End
Support Year
4
Fiscal Year
2001
Total Cost
Indirect Cost
Name
University of Pittsburgh
Department
Type
DUNS #
053785812
City
Pittsburgh
State
PA
Country
United States
Zip Code
15213
McCabe, Stephanie R; Wipf, Peter (2016) Total synthesis, biosynthesis and biological profiles of clavine alkaloids. Org Biomol Chem 14:5894-913
George Rosenker, Kara M; Paquette, William D; Johnston, Paul A et al. (2015) Synthesis and biological evaluation of 3-aminoisoquinolin-1(2H)-one based inhibitors of the dual-specificity phosphatase Cdc25B. Bioorg Med Chem 23:2810-8
Korotchenko, Vasiliy N; Saydmohammed, Manush; Vollmer, Laura L et al. (2014) In vivo structure-activity relationship studies support allosteric targeting of a dual specificity phosphatase. Chembiochem 15:1436-45
Guo, Jianxia; Clausen, Dana M; Beumer, Jan H et al. (2013) In vitro cytotoxicity, pharmacokinetics, tissue distribution, and metabolism of small-molecule protein kinase D inhibitors, kb-NB142-70 and kb-NB165-09, in mice bearing human cancer xenografts. Cancer Chemother Pharmacol 71:331-44
Salum, Lívia B; Altei, Wanessa F; Chiaradia, Louise D et al. (2013) Cytotoxic 3,4,5-trimethoxychalcones as mitotic arresters and cell migration inhibitors. Eur J Med Chem 63:501-10
Wang, Y; Lazo, J S (2012) Metastasis-associated phosphatase PRL-2 regulates tumor cell migration and invasion. Oncogene 31:818-27
Arora, Reety; Shuda, Masahiro; Guastafierro, Anna et al. (2012) Survivin is a therapeutic target in Merkel cell carcinoma. Sci Transl Med 4:133ra56
Kitchens, Carolyn A; McDonald, Peter R; Shun, Tong Ying et al. (2011) Identification of chemosensitivity nodes for vinblastine through small interfering RNA high-throughput screens. J Pharmacol Exp Ther 339:851-8
Vollmer, Laura L; Jiménez, Maria; Camarco, Daniel P et al. (2011) A simplified synthesis of novel dictyostatin analogues with in vitro activity against epothilone B-resistant cells and antiangiogenic activity in zebrafish embryos. Mol Cancer Ther 10:994-1006
Hopkins, Chad D; Schmitz, John C; Chu, Edward et al. (2011) Total synthesis of (-)-CP2-disorazole C1. Org Lett 13:4088-91

Showing the most recent 10 out of 106 publications